Cleared Traditional

K851367 - HA-1000 & HA-500 HYDROXYLAPATITE-MODIFICATION

K851367 is an FDA 510(k) clearance for HA-1000 & HA-500 HYDROXYLAPATITE-MODIFI..., manufactured by Orthomatrix, Inc.. The device is a Class 2 Chemistry device with product code DZE cleared through the Traditional 510(k) pathway after a 46-day FDA review.

K851367 · Orthomatrix, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1985
Decision
46d
Days
Class 2
Risk

K851367 is an FDA 510(k) clearance for the HA-1000 & HA-500 HYDROXYLAPATITE-MODIFICATION. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.

Submitted by Orthomatrix, Inc. (Dublin, US). The FDA issued a Cleared decision on May 21, 1985 after a review of 46 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 872.3640 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Orthomatrix, Inc. devices

FDA 510(k) Submission Details - K851367

510(k) Number K851367 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 1985
Decision Date May 21, 1985
Days to Decision 46 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 88d · This submission: 46d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DZE Device Classification - Class 2, Special Controls

Product Code DZE Implant, Endosseous, Root-form
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DZE Implant, Endosseous, Root-form

All 1105
Devices cleared under the same product code (DZE) and FDA review panel - the closest regulatory comparables to K851367.
IMZ INTRAMOBILE CYLINDER IMPLANT SYSTEM COMPONENTS
K863680 · Interpore Intl. · Oct 1986
SCREW-VENT (TM) IMPLANT/ENDOSSEOUS SCREW IMPLANT
K861426 · Core-Vent Corp. · Oct 1986
IMZ INTRAMOBILE CYLINDER IMPLANT
K855032 · Interpore Intl. · Mar 1986
HYDROXYLAPATITE COATED ENDOSSEOUS DENT
K840750 · Calcitek, Inc. · Apr 1984
BIOLITE CARBON COATED DENTAL IMPLANT
K791491 · Carbomedics, Inc. · Sep 1979
PYROLITE CARBON ENDOSSEOUS DENTAL IMPL
K791237 · Carbomedics, Inc. · Aug 1979